Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease

Sunny, Nishanth E., Parks, Elizabeth J., Browning, Jeffrey D., Burgess, Shawn C.·2011·Cell Metabolism
DOI 10.1016/j.cmet.2011.11.004

Cited by (683)

Items 201–300 of 683

  1. Role of Choline Deficiency in the Fatty Liver Phenotype of Mice Fed a Low Protein, Very Low Carbohydrate Ketogenic Diet
    Rebecca C. Schugar, Xiaojing Huang, Ashley R. Moll, Elizabeth M. Brunt, Peter A. Crawford · 2013 · PLoS ONE
  2. Sex modulates hepatic mitochondrial adaptations to high-fat diet and physical activity
    Colin S. McCoin, Alex T. Von Schulze, Julie Allen, Kelly N. Z. Fuller, Qing Xia, Devin C. Koestler, Claire J. Houchen, Adrianna Maurer, Gerald W. Dorn, Kartik Shankar et al. · 2019 · American Journal of Physiology-Endocrinology and Metabolism
  3. Urinary Loss of Tricarboxylic Acid Cycle Intermediates As Revealed by Metabolomics Studies: An Underlying Mechanism to Reduce Lipid Accretion by Whey Protein Ingestion?
    Haldis H. Lillefosse, Morten Rahr Clausen, Christian Clement Yde, Ditte B. Ditlev, Xumin Zhang, Zhen‐Yu Du, Hanne Christine Bertram, Lise Madsen, Karsten Kristiansen, Bjørn Liaset · 2014 · Journal of Proteome Research
  4. Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis
    Srilaxmi Kalavalapalli, Fernando Bril, Joy Guingab, Ariana Vergara, Timothy J. Garrett, Nishanth E. Sunny, Kenneth J. Cusi · 2019 · Journal of Endocrinology
  5. In vivo stabilization of OPA1 in hepatocytes potentiates mitochondrial respiration and gluconeogenesis in a prohibitin-dependent way
    Lingzi Li, Juliette Martin-Levilain, Cecilia Jiménez‐Sánchez, Mélis Karaca, Michelangelo Foti, Jean‐Claude Martinou, Pierre Maechler · 2019 · Journal of Biological Chemistry
  6. Western Diet Causes Obesity-Induced Nonalcoholic Fatty Liver Disease Development by Differentially Compromising the Autophagic Response
    Inês C. M. Simões, Agnieszka Karkucińska‐Więckowska, Justyna Janikiewicz, Sylwia Szymańska, Maciej Pronicki, Paweł Dobrzyń, Michał Dąbrowski, Agnieszka Dobrzyń, Paulo Jorge Oliveira, Hans Zischka et al. · 2020 · Antioxidants
  7. Improved experimental data processing for UHPLC–HRMS/MS lipidomics applied to nonalcoholic fatty liver disease
    Rainey E. Patterson, Alexander Kirpich, Jeremy P. Koelmel, Srilaxmi Kalavalapalli, Alison M. Morse, Kenneth J. Cusi, Nishanth E. Sunny, Lauren M. McIntyre, Timothy J. Garrett, Richard A. Yost · 2017 · Metabolomics
  8. Resveratrol improves meat quality, muscular antioxidant capacity, lipid metabolism and fiber type composition of intrauterine growth retarded pigs
    Kang Cheng, Caiyun Yu, Zhihua Li, Simian Li, Enfa Yan, Zhihua Song, Hao Zhang, Lili Zhang, Tian Z. Wang · 2020 · Meat Science
  9. Mitochondria-targeted anti-oxidant AntiOxCIN4 improved liver steatosis in Western diet-fed mice by preventing lipid accumulation due to upregulation of fatty acid oxidation, quality control mechanism and antioxidant defense systems
    Amorim, Ricardo, Simões, Inês C.M., Teixeira, José, Cagide, Fernando, Potes, Yaiza, Soares, Pedro, Carvalho, Adriana, Tavares, Ludgero C., Benfeito, Sofia, Pereira, Susana P. et al. · 2022 · Redox Biology
  10. Dietary eicosapentaenoic acid supplementation accentuates hepatic triglyceride accumulation in mice with impaired fatty acid oxidation capacity
    Zhen‐Yu Du, Tao Ma, Bjørn Liaset, Alison H. Keenan, Pedro W. Araujo, Erik‐Jan Lock, Laurent Demizieux, Pascal Degrace, Livar Frøyland, Karsten Kristiansen et al. · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  11. Berberine Reduces Pyruvate-driven Hepatic Glucose Production by Limiting Mitochondrial Import of Pyruvate through Mitochondrial Pyruvate Carrier 1
    Aiyun Li, Qun Liu, Qiang Li, Baolin Liu, Yang Yang, Ning Zhang · 2018 · EBioMedicine
  12. Switching obese mothers to a healthy diet improves fetal hypoxemia, hepatic metabolites, and lipotoxicity in non-human primates
    Stephanie R. Wesolowski, C. Mulligan, R. Janssen, Peter R. Baker, B. Bergman, A. D'Alessandro, T. Nemkov, K. Maclean, Hua Jiang, T. Dean et al. · 2018 · Molecular Metabolism
  13. Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism
    Jorge C. Correia, Julie Massart, Jan Freark de Boer, Margareta Porsmyr‐Palmertz, Vicente Martínez-Redondo, Leandro Z. Agudelo, Indranil Sinha, David Meierhofer, Vera Ribeiro, Marie Björnholm et al. · 2015 · Molecular Metabolism
  14. Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state
    Leanne Hodson · 2018 · Proceedings of The Nutrition Society
  15. miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1
    Kun Li, Bao Lu Zhao, Diandian Wei, Wenrui Wang, Yixuan Cui, Lisheng Qian, Guodong Liu · 2019 · International Journal of Molecular Medicine
  16. Perspectives on youth‐onset nonalcoholic fatty liver disease
    Eduardo Castillo‐Leon, Catherine E. Cioffi, Miriam B. Vos · 2020 · Endocrinology Diabetes & Metabolism
  17. Exercise mitigates age-related metabolic diseases by improving mitochondrial dysfunction
    Dandan Jia, Zhenjun Tian, Ru Wang · 2023 · Ageing Research Reviews
  18. Loss of CTRP5 improves insulin action and hepatic steatosis
    Xia Lei, Susana Rodriguez, Pia Steen Petersen, Marcus Michael Seldin, Caitlyn E. Bowman, Michael J. Wolfgang, Guang William Wong · 2016 · American Journal of Physiology-Endocrinology and Metabolism
  19. In Vivo Estimates of Liver Metabolic Flux Assessed by 13C-Propionate and 13C-Lactate Are Impacted by Tracer Recycling and Equilibrium Assumptions
    Clinton M. Hasenour, Mohsin Rahim, Jamey D. Young · 2020 · Cell Reports
  20. Mitochondria homeostasis: Biology and involvement in hepatic steatosis to NASH
    Yufeng Li, Zhifu Xie, Qian Song, Jing-Ya Li · 2022 · Acta Pharmacologica Sinica
  21. Nutrients, Physical Activity, and Mitochondrial Dysfunction in the Setting of Metabolic Syndrome
    Gabriela Lemos, Raquel Susana Torrinhas, Dan Linetzky Waitzberg · 2023 · Nutrients
  22. The UCP 2 ‐866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.
    Roberta Fares, Salvatore Petta, Rosa Lombardi, Stefania Grimaudo, Paola Dongiovanni, Rosaria Maria Pipitone, Raffaela Rametta, Anna Ludovica Fracanzani, Enrico Mozzi, Antonio Craxı̀ et al. · 2014 · Liver International
  23. High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids
    Sonia Garcia‐Caraballo, Tine M. Comhair, Sander M. Houten, Cornelis H.C. Dejong, Wouter H. Lamers, Eleonore S Köhler · 2014 · The Journal of Nutritional Biochemistry
  24. The effects of voluntary exercise on oocyte quality in a diet-induced obese murine model
    Anna L. Boudoures, Maggie M.-Y. Chi, Alysha S. Thompson, Wendy Zhang, Kelle H. Moley · 2015 · Reproduction
  25. Ultra‐high‐field magnetic resonance spectroscopy in non‐alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non‐alcoholic steatohepatitis and advanced fibrosis
    Stefan Traussnigg, Christian Kienbacher, Martin Gajdošík, Ladislav Valkovič, Emina Halilbasic, Judith Stift, Christian Rechling, Harald Hofer, Petra Steindl‐Munda, Péter Ferenci et al. · 2017 · Liver International
  26. The longevity gene INDY ( I 'm N ot D ead Y et) in metabolic control: Potential as pharmacological target
    Diana M. Willmes, Anica Kurzbach, Christine Henke, Tina Schumann, Grit Zahn, Alexander Heifetz, Jens Jordan, Stephen L. Helfand, Andreas L. Birkenfeld · 2017 · Pharmacology & Therapeutics
  27. Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride‐VLDL Secretion via ApoB Degradation
    Huige Lin, Lin Wang, Zhuohao Liu, Kekao Long, Mengjie Kong, Dewei Ye, Xi Chen, Kai Wang, Kelvin KL Wu, Mengqi Fan et al. · 2022 · Advanced Science
  28. Changes in Key Mitochondrial Lipids Accompany Mitochondrial Dysfunction and Oxidative Stress in NAFLD
    Manon Durand, Marine Coué, Mikaël Croyal, Thomas Moyon, Angela Tesse, Florian Atger, Khadija Ouguerram, David Jacobi · 2021 · Oxidative Medicine and Cellular Longevity
  29. Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration
    Julie Steen Pedersen, Marte Opseth Rygg, Karoline Maise Chrøis, Elahu Gosney Sustarsic, Zachary Gerhart‐Hines, Nicolai J. Wewer Albrechtsen, Reza Serizawa, Viggo Bjerregaard Kristiansen, Astrid Linde Basse, Astrid E. B. Boilesen et al. · 2022 · Nature Communications
  30. Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease
    Boyuan Ma, Anji Ju, Shaosen Zhang, Qi An, Siran Xu, Jie Liu, Li Yu, Yan Fu, Yongzhang Luo · 2023 · Signal Transduction and Targeted Therapy
  31. Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis
    Caroline C. Duwaerts, Jacquelyn J. Maher · 2014 · Current Hepatology Reports
  32. Mitochondrial form, function and signalling in aging
    Ignácio Amigo, Fernanda Marques da Cunha, Maria Fernanda Forni, Wilson Garcia-Neto, Pâmela A. Kakimoto, Luis Alberto Luévano‐Martínez, F.P. Macedo, Sergio L. Menezes‐Filho, Julia Peloggia, Alicia Juliana Kowaltowski · 2016 · Biochemical Journal
  33. Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome
    Matthew C. Sinton, David C. Hay, Amanda Jane Drake · 2019 · Clinical Epigenetics
  34. The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis—Dysregulation by the Liver
    Amalie London, Anne‐Marie Lundsgaard, Bente Kiens, Kirstine Nyvold Bojsen-Møller · 2021 · Journal of Clinical Medicine
  35. Nonalcoholic fatty liver disease, circulating ketone bodies and all‐cause mortality in a general population‐based cohort
    Adrian Post, Erwin Garcia, Eline H. van den Berg, Jose Luis Flores-Guerrero, Eke G. Gruppen, Dion Groothof, Berend Daan Westenbrink, Margery A. Connelly, Stephan J. L. Bakker, Robin P. F. Dullaart · 2021 · European Journal of Clinical Investigation
  36. Baicalein Enhances the Effect of Acarbose on the Improvement of Nonalcoholic Fatty Liver Disease Associated with Prediabetes via the Inhibition of De Novo Lipogenesis
    Yan Xing, Xinxiu Ren, Xia Li, Liping Sui, Xuan Shi, Yu Sun, Chunshan Quan, Zhilong Xiu, Yuesheng Dong · 2021 · Journal of Agricultural and Food Chemistry
  37. Hyperpolarized 13C Magnetic Resonance and Its Use in Metabolic Assessment of Cultured Cells and Perfused Organs
    Lloyd Lumata, Chendong Yang, Mukundan Ragavan, Nicholas Carpenter, Ralph J. DeBerardinis, Matthew E. Merritt · 2015 · Methods in enzymology on CD-ROM/Methods in enzymology
  38. Coral calcium hydride prevents hepatic steatosis in high fat diet-induced obese rats: A potent mitochondrial nutrient and phase II enzyme inducer
    Chen Hou, Yongyao Wang, Erkang Zhu, Chunhong Yan, Lin Zhao, Xiaojie Wang, Yingfeng Qiu, Hui Shen, Xuejun Sun, Zhihui Feng et al. · 2016 · Biochemical Pharmacology
  39. Aronia melanocarpa Extract Ameliorates Hepatic Lipid Metabolism through PPARγ2 Downregulation
    Chung-Hwa Park, Jung‐Hee Kim, Eun Byul Lee, Wonhee Hur, Oh‐Joo Kwon, Hyoung-Jin Park, Seung Kew Yoon · 2017 · PLoS ONE
  40. Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models
    Toshiya Matsukawa, Takashi Yagi, Tohru Uchida, Mashito Sakai, Masaru Mitsushima, Takao Naganuma, Hiroyuki Yano, Yuka Inaba, Hiroshi Inoue, Keisuke Yanagida et al. · 2023 · JCI Insight
  41. The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions
    Salah Abdalrazak Alshehade, Mohammed Abdullah Alshawsh, Vikneswaran Murugaiyah, Muhammad Asif, Omayma Alshehade, Hassan A. Almoustafa, Raghdaa Hamdan Al Zarzour · 2022 · Life Sciences
  42. Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis
    Curtis C. Hughey, Patrycja Puchalska, Peter A. Crawford · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  43. Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease
    Yifei Chen, Fuji Yang, Ying Chu, Zhihua Yun, Yongmin Yan, Jianhua Jin · 2022 · Journal of Translational Medicine
  44. Non‐alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization
    Elizabeth Sabath, Adrian Báez‐Ruíz, Ruud M. Buijs · 2015 · Obesity Reviews
  45. Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis
    Yanqi Dang, Jingjuan Xu, Mingzhe Zhu, Wenjun Zhou, Li Rita Zhang, Guang Ji · 2020 · Biomedicine & Pharmacotherapy
  46. A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis
    Matthew C. Sinton, Jose Meseguer-Ripolles, Baltasar Lucendo‐Villarin, Sara Wernig-Zorc, John P. Thomson, Roderick N. Carter, Marcus J. Lyall, Paul D. Walker, Alpesh Thakker, Richard R. Meehan et al. · 2020 · iScience
  47. Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo
    Himanshi Bhatia, BIJAY RANJAN PATTNAIK, Malabika Datta · 2015 · International Journal of Obesity
  48. Glucagon promotes increased hepatic mitochondrial oxidation and pyruvate carboxylase flux in humans with fatty liver disease
    Kitt Falk Petersen, Sylvie Dufour, Wajahat Zafar Mehal, Gerald I. Shulman · 2024 · Cell Metabolism
  49. Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis
    E. Matthew Morris, Grace Margaret-Eleanor Meers, Lauren G. Koch, Steven L. Britton, Justin A. Fletcher, Xiaorong Fu, Kartik Shankar, Shawn C. Burgess, Jamal A. Ibdah, R. Scott Rector et al. · 2016 · American Journal of Physiology-Endocrinology and Metabolism
  50. Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
    McCommis, Kyle S., Finck, Brian N. · 2019 · Cellular and Molecular Gastroenterology and Hepatology
  51. Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome
    Melanie Cree‐Green, Anne‐Marie Carreau, Haseeb Rahat, Yesenia Garcia‐Reyes, Bryan C. Bergman, Laura Pyle, Kristen J. Nadeau · 2019 · American Journal of Physiology-Endocrinology and Metabolism
  52. Mitochondrial pyruvate carrier function in health and disease across the lifespan
    Buchanan, Jane, Taylor, Eric · 2020 · Biomolecules
  53. Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats
    Michael Ezrokhi, Shuqin Luo, Yelena Trubitsyna, Anthony H. Cincotta · 2014 · Diabetology & Metabolic Syndrome
  54. Mitochondrial Dysfunction-Associated Mechanisms in the Development of Chronic Liver Diseases
    Madan Kumar Arumugam, Thiyagarajan Gopal, Rakhee Rathnam Kalari Kandy, Lokesh Kumar Boopathy, Sathish Kumar Perumal, Murali Ganesan, Karuna Rasineni, Terrence M. Donohue, Natalia A. Osna, Kusum K. Kharbanda · 2023 · Biology
  55. Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease
    Chenyang Mu, Sijie Wang, Zenghan Wang, Jian Tan, Hao-zan Yin, Yuefan Wang, Zhihui Dai, Dongyang Ding, Fu‐Chi Yang · 2024 · Annals of Hepatology
  56. From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations
    Charlotte Green, Camilla Pramfalk, Karl Morten, Leanne Hodson · 2014 · American Journal of Physiology-Endocrinology and Metabolism
  57. Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era
    Annika Ritz, Eberhard Lurz, Michael Berger · 2022 · Cells
  58. Hepatic mTORC1 Opposes Impaired Insulin Action to Control Mitochondrial Metabolism in Obesity
    Blanka Kucejová, João André Gonçalves Duarte, Santhosh Satapati, Xiaorong Fu, Olga Ilkayeva, Christopher B. Newgard, James Brugarolas, Shawn C. Burgess · 2016 · Cell Reports
  59. Measurement of metabolic fluxes using stable isotope tracers in whole animals and human patients
    Julie A. Reisz, Angelo D’Alessandro · 2017 · Current Opinion in Clinical Nutrition & Metabolic Care
  60. Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models
    Charlotte Green, Sion A. Parry, Pippa J. Gunn, Carlo D. L. Ceresa, Fredrik Rosqvist, Marie‐Ève Piché, Leanne Hodson · 2018 · Hormone Molecular Biology and Clinical Investigation
  61. Sodium tanshinone IIA sulfonate ameliorates hepatic steatosis by inhibiting lipogenesis and inflammation
    Xiao-Xiao Li, Xin-Yi Lu, Shijie Zhang, Amy P. Chiu, Lilian H. Lo, David A. Largaespada, Qu-Bo Chen, Vincent W. Keng · 2018 · Biomedicine & Pharmacotherapy
  62. Hepatic hexokinase domain containing 1 (HKDC1) improves whole body glucose tolerance and insulin sensitivity in pregnant mice
    Md. Wasim Khan, Medha Priyadarshini, José Córdoba‐Chacón, Thomas C. Becker, Brian Thomas Layden · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  63. Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease
    Adriana Fontes, Mireia Alemany i Pagès, Paulo Jorge Oliveira, João Ramalho‐Santos, Hans Zischka, Anabela Marisa Azul · 2019 · International Journal of Molecular Sciences
  64. PINE: An Automation Tool to Extract and Visualize Protein-Centric Functional Networks
    Niveda Sundararaman, James L Go, Aaron Robinson, José María Mato, Shelly Chi-Loo Lu, Jennifer E. Van Eyk, Vidya Venkatraman · 2020 · Journal of the American Society for Mass Spectrometry
  65. Inhibition of pyruvate dehydrogenase kinase-4 by l-glutamine protects pregnant rats against fructose-induced obesity and hepatic lipid accumulation
    Kehinde Samuel Olaniyi, Lawrence Aderemi Olatunji · 2018 · Biomedicine & Pharmacotherapy
  66. Disrupted liver oxidative metabolism in glycine N-methyltransferase-deficient mice is mitigated by dietary methionine restriction
    Ferrol I. Rome, Curtis C. Hughey · 2022 · Molecular Metabolism
  67. iTRAQ-based proteomics for studying the effects of dioscin against nonalcoholic fatty liver disease in rats
    Lina Xu, Yongli Wei, Deshi Dong, Lianhong Yin, Yan Qi, Xu Han, Youwei Xu, Yanyan Zhao, Kexin Liu, Jinyong Peng · 2014 · RSC Advances
  68. Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis
    Dhami-Shah, Hiteshi, Vaidya, Rama, Udipi, Shobha, Raghavan, Srividhya, Abhijit, Shiny, Mohan, Viswanathan, Balasubramanyam, Muthuswamy, Vaidya, Ashok · 2018 · Clinical and Molecular Hepatology
  69. Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD
    Muhammed Shafeekh Muyyarikkandy, Marc McLeod, Meghan Maguire, Rohit Mahar, Nathan Kattapuram, Christine Zhang, Chaitra Surugihalli, Vaishna Muralidaran, Kruthi Vavilikolanu, Clayton E. Mathews et al. · 2020 · The FASEB Journal
  70. Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity
    Lytle, Kelli A, Bush, Nikki C, Triay, Jessica M, Kellogg, Todd A, Kendrick, Michael L, Swain, James M, Gathaiya, Nicola W, Hames, Kazanna C, Jensen, Michael D · 2019 · The Journal of Clinical Endocrinology & Metabolism
  71. Monitoring acute metabolic changes in the liver and kidneys induced by fructose and glucose using hyperpolarized [2‐13C]dihydroxyacetone
    Irene Marco‐Rius, Cornelius von Morze, Renuka Sriram, Peng Cao, Gene‐Yuan Chang, Eugene Milshteyn, Robert Bok, Michael A. Ohliger, David Pearce, John V. Kurhanewicz et al. · 2016 · Magnetic Resonance in Medicine
  72. Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients
    Kenichiro Enooku, Mayuko Kondo, Naoto Fujiwara, Takayoshi Sasako, Junji Shibahara, Akira Kado, Kazuya Okushin, Hidetaka Fujinaga, Takeya Tsutsumi, Ryo Nakagomi et al. · 2018 · Journal of Gastroenterology
  73. Glutamate–oxaloacetate transaminase activity promotes palmitate lipotoxicity in rat hepatocytes by enhancing anaplerosis and citric acid cycle flux
    Robert A. Egnatchik, Alexandra K. Leamy, Sarah A. Sacco, Yi Ern Cheah, Masakazu Shiota, Jamey D. Young · 2018 · Journal of Biological Chemistry
  74. Pro‐inflammatory signalling and gut‐liver axis in non‐alcoholic and alcoholic steatohepatitis: Differences and similarities along the path
    Trenton Glaser, Leonardo Baiocchi, Tianhao Zhou, Heather Francis, Ilaria Lenci, Giuseppe B. Grassi, Lindsey Leann Kennedy, Suthat Liangpunsakul, Shannon S. Glaser, Gianfranco D. Alpini et al. · 2020 · Journal of Cellular and Molecular Medicine
  75. The role of mitochondria in the pathophysiology and treatment of common metabolic diseases in humans
    Asen Georgiev, Cesare Granata, Michael Roden · 2022 · American Journal of Physiology-Cell Physiology
  76. Promising therapies for treatment of nonalcoholic steatohepatitis
    Mazen Noureddin, Alice Zhang, Rohit Seth Loomba · 2016 · Expert Opinion on Emerging Drugs
  77. Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests
    Agostino Di Ciaula, Giuseppe Calamita, Harshitha Shanmugam, Mohamad Khalil, Leonilde Bonfrate, David Q.‐H. Wang, György Baffy, Piero Portincasa · 2021 · International Journal of Molecular Sciences
  78. Metformin: update on mechanisms of action on liver diseases
    Gaoyi Ruan, Fangquan Wu, Dibang Shi, Hongxia Sun, Fangyan Wang, Changlong Xu · 2023 · Frontiers in Nutrition
  79. Influence of Liver Triglycerides on Suppression of Glucose Production by Insulin in Men
    Eunsook S. Jin, Magdalene Szuszkiewicz-Garcia, Jeffrey D. Browning, Jeannie D. Baxter, Nicola I. Abate, Craig R. Malloy · 2014 · The Journal of Clinical Endocrinology & Metabolism
  80. Association of gamma‐glutamyl transferase and alanine aminotransferase with type 2 diabetes mellitus incidence in middle‐aged Japanese men: 12‐year follow up
    Kayo Kaneko, Hiroshi Yatsuya, Yuanying Li, Mayu Yasuda Uemura, Chifa Chiang, Yoshihisa Hirakawa, Atsuhiko Ota, Koji Tamakoshi, Atsuko Aoyama · 2018 · Journal of Diabetes Investigation
  81. Dietary fatty acid oxidation is decreased in non‐alcoholic fatty liver disease: A palmitate breath test study
    Gihan Naguib, Nevitt Morris, Shanna B. Yang, Nancy Fryzek, Vanessa Haynes–Williams, Wen‐Chun A. Huang, Jaha Norman‐Wheeler, Yaron Rotman · 2019 · Liver International
  82. Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease
    Yuchang Li, Liting Chen, Lu Li, Chantal M. Sottas, Stephanie K. Petrillo, Anthoula Lazaris, Peter P. Metrakos, Hangyu Wu, Yuji Ishida, Takeshi Saito et al. · 2021 · iScience
  83. Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients
    Fritsch, Maria, Koliaki, Chrysi, Livingstone, Roshan, Phielix, Esther, Bierwagen, Alessandra, Meisinger, Markus, Jelenik, Tomas, Strassburger, Klaus, Zimmermann, Stefanie, Brockmann, Katharina et al. · 2015 · The American Journal of Clinical Nutrition
  84. Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD)
    Irene Mignini, Linda Galasso, Giulia Piccirilli, Valentin Calvez, Fabrizio Termite, Giorgio Esposto, Raffaele Borriello, Luca Miele, Maria Elena Ainora, Antonio Gasbarrini et al. · 2024 · Antioxidants
  85. Dietary carbohydrate and control of hepatic gene expression: mechanistic links from ATP and phosphate ester homeostasis to the carbohydrate-response element-binding protein
    Loranne Agius · 2015 · Proceedings of The Nutrition Society
  86. Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions
    Maria Notarnicola, Alberto Ruben Osella, Maria Gabriella Caruso, Pasqua Letizia Pesole, Antonio Lippolis, Valeria Tutino, Caterina Bonfiglio, Valentina De Nunzio, Maria Principia Scavo, Antonella Mirizzi et al. · 2021 · International Journal of Molecular Sciences
  87. Plasma Thyroid Hormone Concentration is Associated with Hepatic Triglyceride Content in Patients with Type 2 Diabetes
    Fernando Bril, Sushma Kadiyala, Paola Portillo-Sánchez, Nishanth E. Sunny, Diane Biernacki, Maryann Maximos, Srilaxmi Kalavalapalli, Romina Lomonaco, Amitabh Suman, Kenneth J. Cusi · 2016 · Journal of Investigative Medicine
  88. Mechanisms of Adverse Cardiometabolic Consequences of Obesity
    Carlos M Diaz-Melean, Virend Kristen Somers, Juan Pablo Rodríguez-Escudero, Prachi Singh, Ondřej Sochor, Ernesto M. Llano, Francisco Alejandro López-Jiménez · 2013 · Current Atherosclerosis Reports
  89. Loss of Hepatic Oscillatory Fed microRNAs Abrogates Refed Transition and Causes Liver Dysfunctions
    Babukrishna Maniyadath, Tandrika Chattopadhyay, Srikant Prasad Verma, Sujata Kumari, Prineeta Kulkarni, Kushal K. Banerjee, Asmitha Lazarus, Saurabh S. Kokane, Trupti Shetty, Krishanpal Anamika et al. · 2019 · Cell Reports
  90. Metabolomic Biomarkers in the Diagnosis of Non-Alcoholic Fatty Liver Disease
    Saeed Chashmniam, Mohsen Ghafourpour, Azam Rezaei Farimani, Ali Gholami, B. Fatemeh Nobakht M. Gh · 2019 · Hepatitis Monthly
  91. Plasma metabolic alterations in patients with severe obesity and non‐alcoholic steatohepatitis
    Noemí Cabré, Fedra Luciano‐Mateo, Gerard Baiges‐Gayà, Salvador Fernández‐Arroyo, Elisabet Rodríguez‐Tomàs, Anna Hernández‐Aguilera, Marta París, Fàtima Sabench, Daniel Del Castillo, José López‐Miranda et al. · 2019 · Alimentary Pharmacology & Therapeutics
  92. Pcyt2 deficiency causes age-dependant development of nonalcoholic steatohepatitis and insulin resistance that could be attenuated with phosphonoethylamine
    Sophie Grapentine, Rathnesh K. Singh, Poulami Basu, Sugashan Sivanesan, Gabriela Ponte de Mattos, Oreoluwa Oresajo, Jasmine Cheema, Wendwesen Demeke, Vernon Wayne Dolinsky, Marica Bakovic · 2022 · Scientific Reports
  93. Metabolomic signatures in lipid‐loaded HepaRGs reveal pathways involved in steatotic progression
    Meredith V. Brown, Sarah A. Compton, Michael V. Milburn, Kay A. Lawton, Bentley Cheatham · 2013 · Obesity
  94. Insulin Activation of Plasma Nonesterified Fatty Acid Uptake in Metabolic Syndrome
    María A. Ramos-Román, Smadar A. Lapidot, Robert D. Phair, Elizabeth Jane Parks · 2012 · Arteriosclerosis Thrombosis and Vascular Biology
  95. Synthesis and Biological Evaluation of Novel Bouchardatine Derivatives as Potential Adipogenesis/Lipogenesis Inhibitors for Antiobesity Treatment
    Yong Rao, Hong Liu, Lin Gao, Hong Yu, Tian‐Miao Ou, Jia‐Heng Tan, Shi‐Liang Huang, Honggen Wang, Ding Li, Lian‐Quan Gu et al. · 2015 · Journal of Medicinal Chemistry
  96. The link between Hepatic Vitamin A Metabolism and Nonalcoholic Fatty Liver Disease
    Guoxun Chen · 2015 · Current Drug Targets
  97. Relationship between serum β-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD
    Mary P. Moore, Grace E. Shryack, Isabella G. Alessi, Nicole Wieschhaus, Grace Margaret-Eleanor Meers, Sarah A. Johnson, Andrew A. Wheeler, Jamal A. Ibdah, Elizabeth Jane Parks, R. Scott Rector · 2024 · American Journal of Physiology-Endocrinology and Metabolism
  98. Tracer-based assessments of hepatic anaplerotic and TCA cycle flux: practicality, stoichiometry, and hidden assumptions
    Stephen F. Previs, David E. Kelley · 2015 · American Journal of Physiology-Endocrinology and Metabolism
  99. Pigment Epithelium-Derived Factor (PEDF) Suppresses IL-1β-Mediated c-Jun N-Terminal Kinase (JNK) Activation to Improve Hepatocyte Insulin Signaling
    Arijeet K. Gattu, Andreas L. Birkenfeld, Yasuko Iwakiri, Steven M. Jay, W. Mark Saltzman, Jennifer A. Doll, Petr Protiva, Varman T. Samuel, Susan E. Crawford, Chuhan Chung · 2014 · Endocrinology
  100. Increased lipogenesis in spite of upregulated hepatic 5'AMP‐activated protein kinase in human non‐alcoholic fatty liver
    Christian von Loeffelholz, Stephanie Döcke, Johan Friso Lock, Stefanie Lieske, Paul Horn, Jennifer Kriebel, Simone Wahl, Paula Singmann, Tonia de las Heras Gala, Harald Grallert et al. · 2016 · Hepatology Research